Precigen (PGEN) Preferred Dividend Payments (2012 - 2025)

Precigen (PGEN) reported Preferred Dividend Payments of $179.0 million for Q3 2025, up 873.3% quarter-over-quarter from $18.4 million in Q4 2013.

Precigen (PGEN) Preferred Dividend Payments (2012 - 2025) Analysis & Trends

Precigen (PGEN) has 3 years of Preferred Dividend Payments data on file, last reported at $179.0 million in Q3 2025.

Preferred Dividend Payments for Q3 2025 came in at $179.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $179.0 million (changed N/A YoY), and the FY2025 annual result was $179.0 million, changed N/A from the prior year.
Preferred Dividend Payments advanced to $179.0 million in Q3 2025 per PGEN's latest filing, from $18.4 million in the prior quarter.
Over five years, Preferred Dividend Payments peaked at $179.0 million in Q3 2025 and troughed at $179.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Precigen	1.27 Bn	1.27 Bn	20.69 Mn	-

Download Data